Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Syngenta buys AZN seed business

AstraZeneca (LSE:AZN; AZN) and Royal Cosun (Breda, the Netherlands) agreed to sell their Advanta joint venture

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE